Skip to main content

Table 1 Baseline characteristics at the time of diagnosis of cirrhosis in Halland, 2011–2018

From: Incidence, aetiology and related comorbidities of cirrhosis: a Swedish population-based cohort study

 AlcoholHCVCryptogenicNAFLDPBCAIHOther causesOverall
Overall, n (%)302 (50.5)80 (13.4)87 (14.5)34 (5.7)31 (5.2)30 (5.0)34 (5.7)598 (100)
Male, n (%)212 (70)55 (69)59 (68)19 (56)5 (16)6 (20)24 (71)380 (64)
Female, n (%)90 (30)25 (31)28 (32)15 (44)26 (84)24 (80)10 (29)218 (36)
Median age (years) (10–90 percentile)65 (52–76)57 (46–67)76 (63–88)75 (62–86)72 (58–81)69 (46–85)64 (30–83)66 (50–81)
Comorbidities, n (%)
 Hypertension96 (32)17 (21)32 (37)23 (68)12 (39)7 (23)9 (27)196 (33)
 Ischaemic heart disease59 (20)4 (5)27 (31)11 (32)7 (23)2 (6.7)4 (12)114 (19)
 Chronic heart failure37 (12)2 (2.5)35 (40)8 (24)1 (3.2)0 (0)3 (8.8)86 (14)
 Type 2 diabetes78 (26)6 (21)37 (43)18 (53)9 (29)4 (13)8 (24)171 (29)
 Obesity a81 (27)18 (23)10 (11)24 (70)4 (13)5 (17)1 (2.9)143 (24)
Severity, n (%)b
 MELD (median)14911.596101011
 MELD < 1070 (23)49 (61)30 (34)16 (47)23 (74)14 (47)14 (41)216 (36)
 MELD 10–1584 (28)11 (15)19 (22)6 (18)4 (13)6 (20)11 (32)142 (24)
 MELD ≥15140 (46)18 (23)27 (31)9 (26)1 (3.2)9 (30)6 (18)210 (35)
 Child-Pugh A80 (26)48 (60)19 (22)16 (47)24 (77)15 (50)16 (47)217 (36)
 Child-Pugh B122 (40)21 (26)47 (54)12 (35)4 (13)10 (33)12 (35)228 (38)
 Child-Pugh C91 (30)11 (15)10 (11)3 (8.8)0 (0)4 (13)3 (8.8)122 (20)
 Baveno IV, 1–2121 (40)53 (66)33 (38)25 (74)28 (90)22 (73)23 (68)305 (51)
 Baveno IV, 3–4181 (60)27 (34)54 (62)9 (26)3 (10)8 (27)11 (32)292 (49)
Complications, n (%)
 Any complication227 (75)44 (55)74 (85)23 (68)7 (21)15 (50)19 (56)409 (68)
 Ascites175 (58)24 (30)52 (60)8 (24)3 (10)8 (27)10 (29)280 (47)
 Oesophageal varices119 (39)26 (33)31 (36)13 (38)4 (13)9 (30)13 (38)215 (36)
 Variceal bleeding19 (6.3)4 (5)6 (6.9)1 (2.9)0 (0)1 (3.3)1 (2.9)32 (5.4)
 Portal vein thrombosis10 (3.3)7 (8.8)10 (11)0 (0)0 (0)0 (0)5 (15)32 (5.4)
 Encephalopathy34 (11)5 (5)2 (2.3)1 (2.9)0 (0)2 (6.7)0 (0)43 (7.2)
 Spontaneous bacterial peritonitis5 (1.7)1 (1.3)0 (0)0 (0)1 (3.2)0 (0)1 (2.9)8 (1.3)
 Hepatocellular carcinoma21 (6.9)16 (20)29 (33)5 (15)1 (3.2)1 (3.3)2 (5.9)75 (13)
  1. AIH Autoimmune Hepatitis, HCV Hepatitis C, MELD Model for End-Stage Liver Disease, NAFLD Non-alcoholic Fatty Liver Disease, PBC Primary Biliary Cholangitis
  2. aObesity defined as body mass index > 30 kg/m2
  3. bMELD-score and Child Pugh-score calculated for 95% of patients